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WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT? 79 
 Most of the studies to date have been focused on the interplay between FTO gene and 80 
self-reported physical activity.  81 
 However, measurement errors associated to a self-reported nature of questionnaires 82 
may have attenuated the true strength of the gene-physical activity interplay.  83 
 Limited data is available on objective measured physical activity and its interaction with 84 
the FTO gene on obesity-related markers.  85 
 86 
WHAT DOES YOUR STUDY ADD? 87 
 Our findings emphasise that physical activity may be a particularly effective way of 88 
controlling body weight in individuals with a genetic predisposition towards obesity. 89 
 The apparent effect of an active lifestyle on genetic predisposition to obesity (~4kg 90 
differences in the FTO-related effect size on body mass for inactive vs active individuals) 91 
is large enough to be clinically relevant. 92 
 93 
 94 
 95 
 96 
  97 
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ABSTRACT (words=198) 98 
Objective: To examine whether the effect of FTO loci on obesity-related traits could be 99 
modified by physical activity (PA) levels in European adults.  100 
Methods: Of 1,607 Food4Me participants randomised, 1,280 were genotyped for the FTO 101 
(rs9939609) and had available PA data. PA was measured objectively using accelerometers 102 
(TracmorD, Philips), whereas anthropometric measures (BMI, and waist circumference; WC) 103 
were self-reported via the internet.  104 
Results: FTO genotype was associated with a higher body weight (β: 1.09 kg per risk allele, 105 
[95%CI: 0.14-2.04]; P=0.024), BMI (β: 0.54 kg.m-2, [0.23-0.83]; P<0.0001) and WC (β: 1.07 cm, 106 
[0.24-1.90]; P=0.011). Moderate-equivalent PA attenuated the effect of FTO on BMI 107 
(P[interaction]=0.020). Among inactive individuals, FTO increased BMI by 1.06 kg.m-2 per allele 108 
(p=0.024) whereas the increase in BMI was substantially attenuated among active individuals 109 
(0.16 kg.m-2, p=0.388). We observed similar effects for WC (P[interaction]=0.005): the FTO risk allele 110 
increased WC by 2.72 cm per allele among inactive individuals but by only 0.49 cm in active 111 
individuals.      112 
Conclusions: PA attenuates the effect of FTO genotype on BMI and WC. This may have 113 
important public health implications because genetic susceptibility to obesity in the presence of 114 
FTO variants may be reduced by adopting a physically active lifestyle. 115 
 116 
 117 
  118 
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INTRODUCTION 119 
Changes in lifestyle, including higher energy intake and lack of physical activity (PA), have been 120 
the driving force behind the dramatic increase in obesity prevalence over the past three 121 
decades (1, 2). The prevalence of obesity has increased markedly, with 16.6% of European 122 
adults (3) and 9.3% of adults globally now having obesity (4). However, epidemiological studies 123 
show that genetic factors play an important role in the development of obesity (5), suggesting 124 
that obesity is a multifactorial condition influenced by a complex interplay between lifestyle 125 
and genetics (2, 5, 6).  126 
Recent genome wide association studies have identified single nucleotide polymorphisms 127 
(SNPs) in genes (7), including the fat mass and obesity-associated gene (FTO), that are strongly 128 
associated with the development of obesity (7, 8, 9, 10). A study of 38,759 individuals revealed 129 
that subjects homozygous for the FTO (rs9939609) risk allele weighed on average 3kg more and 130 
had 1.7-fold increased odds of being obese compared with individuals homozygous for the 131 
lower-risk allele (10). Although the evidence for an effect of FTO, or other obesity-related loci, 132 
on obesity is strong, the variance in BMI explained by genetic variants is small (2.7%) (11, 12). 133 
This is in stark contrast with earlier studies of the heritability of BMI, which was estimated to be 134 
40-70% (5, 13). Gene-lifestyle interactions may contribute to the unexplained heritability of BMI 135 
and obesity (14, 15), and numerous such interactions for many different cardio-metabolic 136 
phenotypes, including obesity anthropometrics, were recently catalogued from 386 published 137 
scientific reports (16). Much work remains to determine how robust these interactions are. Still, 138 
modulation of FTO-obesity associations by self-reported (SR) PA is one of the most replicated 139 
(16). 140 
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Although genetically predisposed individuals may be more susceptible to obesity in an 141 
obesogenic environment, with a higher risk of over-consumption as was shown in twin studies 142 
(13), there has been limited evidence of genotype-lifestyle interactions on adiposity outcomes 143 
(6, 17). Importantly, most of the studies to date have focused on the interplay between genes 144 
and self-reported (SR) PA, where measurement error in SR PA may have attenuated the true 145 
strength of the gene-PA interaction (18). To date, only very few studies have used objectively 146 
measured PA to examine the FTO-PA interaction in adults (19, 20). Therefore, in the current 147 
study, we investigated whether the effect of the FTO loci on obesity-related traits was modified 148 
by objectively measured PA in European adults from the Food4Me study.  149 
 150 
METHODS  151 
Study population 152 
The Food4Me Proof of Principle (PoP) study was a 6-month, 4-arm, internet-based, randomised 153 
controlled trial (RCT) conducted across 7 European countries (www.food4me.org) (21). 1,607 154 
participants from the following recruitment sites: University College Dublin (Ireland), 155 
Maastricht University (The Netherlands), University of Navarra (Spain), Harokopio University 156 
(Greece), University of Reading (United Kingdom, UK), National Food and Nutrition Institute 157 
(Poland), and Technical University of Munich (Germany), were randomised into the RCT. 158 
Participants recruited and randomised per country has been described elsewhere(21, 22). 159 
Participants aged ≥18 years of age were included in the study. To keep the cohort as 160 
representative as possible of the adult European population, a minimal set of exclusion criteria 161 
were applied as described elsewhere (21). 162 
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 163 
Study measures 164 
Participants consented to self-report their measures via the internet and to send biological 165 
samples (Dried Blood Spot cards and buccal swabs) by post, using pre-paid, stamped addressed 166 
envelopes. To ensure that procedures were similar in all recruiting centres, standardised 167 
operating procedures were prepared for all measurements, and researchers underwent 168 
centralised training. Moreover, to enable participants to collect and report the required 169 
information and to collect, process and dispatch the biological samples correctly, participants 170 
were given printed detailed instructions, and video demonstrations of key procedures were 171 
available online. All instructions were provided in the language of the country of recruitment 172 
(21). 173 
 174 
Collection of demographic and anthropometric data  175 
An online screening questionnaire collected detailed SR information on demographic, food 176 
choices, health-related and anthropometric data. At baseline, body weight, height and waist 177 
circumference (WC) were self-measured and self-reported by participants via the internet. 178 
Participants were instructed to measure body weight after an overnight fast, without shoes and 179 
wearing light clothing using a home or commercial scale, and to measure height, barefoot, 180 
using a standardised measuring tape provided by Food4Me (21). WC was measured at the mid-181 
point between the lower rib and the iliac crest using the provided tape measure. Central 182 
obesity was defined as WC >88 cm for women and >102 cm for men. BMI was calculated from 183 
body weight and height. Adiposity status was defined using WHO criteria for BMI 184 
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(underweight<18.5 kg.m-2, normal weight ≥18.5 kg.m-2 to ≤24.9 kg.m-2, overweight ≥25.0kg.m-2 185 
to ≤29.9 kg.m-2 and obese ≥30.0 kg.m-2). SR measurements were validated in a sub-sample of 186 
the participants (n=140) and showed a high degree of reliability (23).  187 
 188 
Physical activity measures and analysis 189 
Physical activity levels (PAL) and time spent in sedentary behaviours were measured objectively 190 
using triaxial accelerometers (TracmorD, Philips Consumer Lifestyle, The Netherlands) (24). All 191 
participants were instructed to wear the accelerometer every day during waking hours, except 192 
when taking a shower, for the whole duration of the study. For the analyses reported in this 193 
paper, data collected over 2 weeks at baseline were used. Participants were instructed to 194 
upload their PA data into the study server via the internet. 195 
Data were recorded with a time sampling interval of 1 min (i.e. 1-min epochs). A day was 196 
considered valid if the volunteer had worn the TracmorD for at least 10 hours, but not longer 197 
than 18 hours. Wear time was defined as 24 hours minus non-wear time. To define non-wear 198 
time, we adapted the recommendations of Choi et al. (25) to the TracmorD. The R software 199 
version 3.1.2 was used for PA data processing.  200 
PA domains were based on application of thresholds for activity energy expenditure (AEE) and 201 
included time spent in sedentary behaviours (corresponding to <1.5 METs), light (1.5 to <3 202 
METs), moderate (3 to <6 METs), vigorous (≥6 METs) or moderate-equivalent intensity PA (26). 203 
Moderate-equivalent PA was derived using the following equation [moderate PA + (vigorous PA 204 
* 2)] (27).   205 
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Adherence to the WHO physical activity recommendations was examined by estimating the 206 
proportion of volunteers who accumulated at least 150 minutes per week of moderate PA or 75 207 
minutes of vigorous PA or an equivalent combination of moderate and vigorous PA, in bouts of 208 
at least 10 minutes (27). This translates to at least 150 minutes per week of moderate-209 
equivalent PA. Three-categorical variables were created for all PA variables. For the moderate-210 
equivalent PA variable, 150 and 300 min.week-1 of moderate-equivalent PA were used to create 211 
3 relevant categories. Similarly, for the moderate PA variable, 150 and 300 min.week-1 of 212 
moderate PA were used to create the 3 categories. For all other PA variables, categories were 213 
tertiles derived from STATA.  214 
 215 
Genotypic analyses 216 
Buccal cell samples were collected from participants at baseline using Isohelix SK-1 DNA buccal 217 
swabs and Isohelix dried-capsules and posted to each recruiting centre for shipment to LGC 218 
Genomics (Hertfordshire, United Kingdom). LGC Genomics extracted DNA and genotyped 219 
specific loci using KASPTM genotyping assays. FTO SNPs (rs9939609 and rs1121980) were 220 
genotyped and showed a high linkage disequilibrium (r2=0.96). Therefore, results for rs1121980 221 
are not reported. Accuracy of the genotyping analysis has been assessed and reported 222 
elsewhere(23). 223 
A goodness-of-fit chi-square test was performed to examine if the observed genotype counts 224 
were in Hardy-Weinberg equilibrium. Genotype frequency for the FTO rs9939609 variant did 225 
not deviate from Hardy-Weinberg equilibrium (TT=469, TA=739 and AA=264, P=0.345). 226 
 227 
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Ethics approval and participant consent 228 
The Research Ethics Committees at each University or Research Centre delivering the 229 
intervention granted ethics approval for the study. The Food4Me trial was registered as a RCT 230 
(NCT01530139) at www.clinicaltrials.gov. All participants who expressed an interest in the 231 
study were asked to sign online consent forms at two stages in the screening process. These 232 
forms were automatically directed to the local study investigators to be counter-signed and 233 
archived (21). 234 
 235 
Statistical analysis 236 
Baseline data were used for the present analyses. Results from descriptive analyses are 237 
presented as means and SD for continuous variables and as percentages for categorical 238 
variables.  239 
Robust Linear Regression analyses were used to test for associations between the main 240 
outcomes (weight, BMI and WC) and FTO genotype. FTO was coded using an additive genetic 241 
model (TT=0, AT=1, AA=2) and PA was categorized and coded as ordinal variable (0=Lower, 242 
1=Middle, 2=Higher). The interplay between PA and FTO genotype was investigated by 243 
including an interaction term in the models, with PA and FTO variables coded as specified 244 
above. For categorical outcomes (% of participants with overweight or obesity), Robust Logistic 245 
Regression was used and FTO and PA (coded as ordinal variables) were included in the model 246 
using an interaction term. Analyses were adjusted for age, sex, country, season and monitor 247 
wearing time, as appropriate. Results were deemed significant at P<0.05. Data were analysed 248 
using Stata (version 13; StataCorp. College Station, TX, USA). 249 
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 250 
RESULTS 251 
Cohort characteristics 252 
Of the 1,607 individuals randomised into the Food4Me study, data at baseline on FTO genotype 253 
and PA were available for 1,280 participants (58% were women and 97% were Caucasians). As 254 
summarised in Table 1, 30% of individuals had overweight and 16% had obesity. In addition, WC 255 
was above the healthy limit (>102 cm for males and 88 cm for females) for 23% of males and 256 
26% of females. Although 57% of men and 40% of women met the PA recommendation (≥150 257 
minutes of moderate-equivalent PA a week), 28% of the participants recorded less than 1 258 
minute of vigorous intensity PA daily. All PA variables were significantly associated with 259 
obesity–related markers (Table S5). 260 
Association of FTO genotype with obesity measures 261 
Carriage of the A allele of the FTO rs9939609 variant was associated with higher body weight 262 
[β: 1.09 kg increase per risk allele, 95%CI (0.14 to 2.04), P=0.024], BMI [β: 0.54 kg.m-2, 95%CI 263 
(0.23 to 0.83), P<0.0001], and WC [β: 1.07 cm, 95%CI (0.24 to 1.90), P=0.011] (Figure 1). 264 
Participants with the FTO risk allele (A) had significantly higher odds of having overweight (OR: 265 
1.27 (1.06 to 1.51), P=0.007) or obesity (OR: 1.41 (1.13 to 1.75); P=0.003) than individuals with 266 
the T allele, but no significant association was found for central obesity (Table 2). 267 
Interaction between FTO genotype and PA levels on adiposity 268 
We found a significant interaction between FTO genotype and category of moderate-equivalent 269 
PA on body weight, BMI and WC (Table 3 and Figure 2). The strength of the association 270 
between FTO and body weight decreased with increasing moderate-equivalent PA: the 271 
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relationship declined from 3.53 kg (95%CI: 0.93 to 6.11) per copy of the FTO risk allele in 272 
participants with lower levels of PA (<150 min.week-1) to -0.28 kg (95%CI: -1.48 to 0.91) in 273 
participants with higher levels of PA (>300 min.week-1), as shown in Table 3 and Figure 2. 274 
Similar results were found for BMI (lower PA: 1.06 kg.m-2 vs higher PA: 0.16 kg.m-2 per copy of 275 
the risk allele, P(interaction)=0.020) and WC (lower PA: 2.72 cm vs higher PA: -0.49 cm per copy of 276 
the risk allele, P(interaction)=0.005). When the relationship between FTO genotype and other PA 277 
domains (vigorous, moderate and light intensity PA) were studied, we observed significant 278 
interactions between FTO*vigorous intensity PA (Table S1 and Figure S1) and FTO*moderate 279 
intensity PA (Table S2 and Figure S2) on body weight, BMI and WC. However, no significant 280 
FTO*light intensity PA interactions were identified (Table S3 and Figure S3). Although there 281 
were no significant interactions between FTO genotype and sedentary behaviour on obesity 282 
measures (body weight, BMI and WC), these increased with increasing time spent in sedentary 283 
behaviour (Table S4 and Figure S4). The effect size of FTO on BMI and WC was 60% and 320% 284 
greater in individuals with longer, than shorter, time spent in sedentary behaviour, respectively. 285 
When additional analyses were performed and PA was included in the interaction models as a 286 
continuous variable, we saw a similar trend for the interaction effect between FTO and PA-287 
related variables but these interaction were no longer significant (P>0.05) for any of the 288 
outcomes. Additionally, no association were found between PA variables and FTO genotype 289 
(Table S6). Sensitivity analysis where participants of non-white ethnic origin (<3%) were 290 
removed from the analysis did not modify any of our findings.   291 
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Discussion  292 
Main findings 293 
Our main findings are that, on average, each additional copy of the FTO risk allele at rs9939609 294 
was associated with significant increases in body weight, BMI and WC of 1.09 kg, 0.54 kg.m-2 295 
and 1.07 cm, respectively. Consistently, each copy of the risk allele increased the odds of having 296 
overweight or obesity by 32%. Our results provide further evidence to support the interplay 297 
between genes and lifestyle. We showed that the effect sizes of the FTO associations on BMI 298 
and WC for active individuals (moderate-equivalent PA >300 min.week-1) were 85% and 118% 299 
lower, respectively, than for inactive individuals (moderate-equivalent PA <150 min.week-1). 300 
These findings emphasise the importance of PA in the prevention of obesity especially in 301 
subjects carrying the FTO risk allele.  302 
 303 
Comparison with other studies 304 
Our results are consistent with the findings of previous studies showing associations between 305 
FTO variants and obesity-related traits (10, 28, 29). Although the effect size of the FTO 306 
rs9939609 is relatively modest, it is consistent across studies conducted in Caucasian 307 
populations (10, 28, 29, 30, 31). Our FTO effect size estimates are in agreement with previous 308 
findings where each copy of the risk allele was associated with an increase in adiposity 309 
measures ranging from 0.76 to 2.4 cm for WC, and from 0.31 to 0.66 kg.m-2 for BMI, which is 310 
equivalent to ~1.3 to 2.1 kg in body weight for an individual 1.80 m tall (8, 9, 10, 28, 30). 311 
Similarly, the odds of having overweight or obesity reported in previous studies ranged from 312 
~1.19 to 1.69 per additional copy of the risk allele (8, 9, 10, 28, 29), which is in agreement with 313 
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our estimates (OR: 1.27 (1.06 to 1.51) for overweight and OR: 1.41 (1.13 to 1.75) for obesity per 314 
copy of the risk allele).   315 
Furthermore, our study suggests that an active lifestyle may attenuate the FTO genetic 316 
susceptibility to obesity (19, 20, 32, 33). A meta-analysis of cross-sectional studies, including 317 
218,166 adults (19), reported a significant FTO*PA interaction (P=0.001), where the minor A 318 
FTO allele of the rs9939609 variant increased the odds of being obese less in physically active 319 
individuals [OR: 1.22 (95%CI 1.19-1.25)] than among inactive individuals (OR: 1.30 (1.24-1.36)]. 320 
Moreover, the latter meta-analysis reported that the association of the FTO genotype with BMI 321 
and WC was attenuated in physically active individuals (0.32 kg.m-2 and 0.68 cm per copy of the 322 
risk allele, respectively) compared with inactive individuals (0.46 kg.m-2 and 1.01 cm per copy of 323 
the risk allele). Although our study showed qualitatively similar findings, we observed a bigger 324 
attenuation by PA of the effect of FTO on obesity-related traits. This quantitative difference 325 
between studies may be explained by the relative precision of PA measurements.  326 
Our results are based on objectively measured PA data whereas the earlier meta-analysis (19) 327 
used primarily SR PA data. SR PA can be subject to optimistic bias leading to PA overestimation 328 
(34). Furthermore, SR PA is prone to random error, which leads to regression dilution bias (35).  329 
This can obscure the true effect of PA on the interplay between genes and environment (36).  330 
Moreover, the use of categories of PA may provide better knowledge of the dose-response 331 
relationship between FTO genotype and PA on adiposity, which may assist in identifying the 332 
minimum amount of PA necessary to overcome the genetic effect of FTO genotype on obesity-333 
related traits. We found that the influence of the FTO risk allele on BMI was 36% and 84% lower 334 
in individuals achieving between 150-300 min.week-1 or above 300 min.week-1 of moderate 335 
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equivalent PA, respectively, than in inactive individuals (<150 min.week-1). The attenuating 336 
effect of PA on FTO related adiposity was similar when WC was used as an outcome (the FTO 337 
risk allele effect on WC was 1.5 and 6.5-fold lower for active and highly active individuals than 338 
in inactive individuals).  339 
Although previous studies have reported a significant FTO*PA interaction (20, 30, 31, 32, 33, 340 
37), most of these studies used SR PA (19). Objectively measured PA allowed us to investigate 341 
whether sedentary behaviours or other PA domains, such as light, moderate and vigorous 342 
intensity PA, modulate the effect of the FTO genotype on obesity-related traits. We identified 343 
that achieving between 10 to 90 minutes of vigorous PA per week mitigated the effect of FTO 344 
genotype on obesity measures. However, higher levels of moderate intensity PA appear to be 345 
needed (150 to 300 min.week-1) to achieve similar attenuating effects on the association 346 
between FTO genotype and obesity.  347 
The mechanism how the FTO gene may have an impact on obesity outcomes remains unclear. 348 
Recent evidence suggests that genetic variants within introns 1 and 2 of FTO may change the 349 
basic function of human adipocytes from substrate storage to fuel utilization through enhanced 350 
thermogenesis (38). Claussnitzer et al. proposed that noncoding variants in FTO influence the 351 
thermogenic capacity of beige cells, which results in phenotypic differences in BMI. They 352 
identified a large enhancer region in the FTO locus of adipocytes that has long-range control 353 
over two homeobox regulatory genes, IRX3 and IRX5, and demonstrated cell-autonomous 354 
effects of these genes by means of genetic knockdown of IRX3 and IRX5 to restore 355 
thermogenesis in adipocytes from persons at high genetic risk for obesity. In contrast, 356 
overexpression of these proteins in adipocytes from persons without this genetic risk resulted 357 
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in decreased mitochondrial function and thermogenesis (38). Some attempts have been made 358 
to explain the relationship between FTO and PA energy expenditure (39), but there is 359 
inconclusive evidence on whether this may be due to epistatic gene interactions with other 360 
genes that may control PA or dietary intake, or to gene-environment interaction (39).   361 
The strengths of our study include the objective measure of PA in a large European cohort, 362 
which is important because the identification of convincing gene-lifestyle interactions requires 363 
accurate measures of the environmental exposure (18) to make them as robust basis for public 364 
health action. Moreover, our estimate of PA allowed us to create categories of PA domains 365 
which revealed the dose-response relationship for gene-environment interaction. A potential 366 
limitation of our study is that anthropometric data were self-measured and self-reported via 367 
the internet, which may have introduced measurement error. Nonetheless, the accuracy of 368 
internet-based, self-reported anthropometric data is high (40) and this has been confirmed in 369 
our study (23). However, we cannot completely discard any confounding effect of self-reported 370 
data on our main outcomes.  Another factor that should be considered as a limitation is the lack 371 
of information on relatedness of the individuals. Additionally, when interactions between 372 
FTO and PA were assessed by fitting PA as a continuous variable in the interaction term, the 373 
trend remained similar but the interactions were no longer statistically significant (P>0.05). 374 
A larger sample size will be needed to confirm our findings using PA as a continuous 375 
variable. Furthermore, by design, we recruited individuals interested in taking part in a 376 
personalized intervention on nutrition and lifestyle, which is less representative than a 377 
European-wide survey. Nonetheless, our participants were broadly representative of the 378 
European adult population, most of whom had adequate nutrient intakes but could benefit 379 
from improved dietary choices and greater PA [41]  380 
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 381 
Implications of findings 382 
Considering the current prevalence of overweight and obesity worldwide (4), our findings are 383 
highly relevant for improving public health. They emphasise that PA may be a particularly 384 
effective way of controlling body weight in individuals with a genetic predisposition towards 385 
obesity and thus contrast with the deterministic view that genetic influences are unmodifiable. 386 
The apparent effect of an active lifestyle on genetic predisposition to obesity (~4kg differences 387 
in the FTO-related effect size on body mass for inactive vs active individuals) is large enough to 388 
be clinically relevant. Evidence of such gene–lifestyle interactions may empower and motivate 389 
individuals to adopt healthier lifestyle behaviours through knowledge that such behaviour 390 
change can be effective in preventing obesity and, therefore, risk of obesity-related non-391 
communicable diseases. Gene*environment interactions for cardio-metabolic phenotypes 392 
involve physical activity more often than any other lifestyle factor, including dietary fat intakes 393 
(16). 394 
In conclusion, despite the fact that FTO genotype is robustly associated with BMI and WC, our 395 
results show that higher PA attenuates this genetic predisposition to obesity-related traits. 396 
These finding are relevant for public health and suggest that promoting PA, particularly in those 397 
who are genetically susceptible, is an important strategy for addressing the current obesity 398 
epidemic.  399 
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Figure 1. Association between FTO rs9939609 genotype and adiposity measures.  551 
Least-squares means of genotypes were calculated by using Robust Linear Regression, with 552 
adjustment for age, sex and country. 553 
 554 
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Figure 2. Effect of the FTO rs9939609 genotype on adiposity-measures by category of 558 
moderate-equivalent physical activity.   559 
P values are for the interaction between the FTO variant and PA category; Least-squares means 560 
of different genotypes across all PA groups were calculated by using Robust Linear Regression 561 
Analysis, with adjustment for age, sex, country, monitor wear time and season. Allele frequency 562 
by PA category were (Lower: 71/158/59; Middle: 103/142/61; Upper: 231/342/113) for TT, TA 563 
and AA genotypes, respective. 564 
 565 
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Table 1.  Characteristics of Food4Me Study participants 576 
Variables Overall  Men Women 
n 1280 537 743 
Age (years) 39.9 (13.0) 41.6 (13.4) 38.7 (12.5) 
Anthropometric    
Height (m) 1.71 (0.09) 1.79 (0.07) 1.65 (0.06) 
Body weight (kg) 74.7 (15.8) 83.4 (13.5) 68.5 (14.3) 
BMI (kg.m-2) 25.5 (4.8) 26.1 (4.1) 24.9 (5.2) 
Underweight (<18.5 kg.m-2; %) 2.6 0.8 3.8 
Normal weight (≥18.5 to <25.0 kg.m-2; %) 51.3 44.7 56.0 
Overweight (≥25.0 to <30.0 kg.m-2; %) 30.3 38.4 24.6 
Obese (≥30.0 kg.m-2; %) 15.8 16.1 15.6 
Waist Circumference (cm) 85.7 (13.8) 92.7 (12.1) 80.7 (12.8) 
Central obesity* (%) 24.3 22.8 25.6 
Physical Activity     
PAL 1.73 (0.18) 1.74 (0.2) 1.72 (0.2) 
Sedentary time (min.day-1) 744.8 (76.6) 738.9 (82.3) 749.1 (71.5) 
Light PA (min.day-1) 73.9 (30.4) 74.0 (29.8) 73.9 (30.9) 
Moderate PA (min.day-1) 33.3 (20.4) 37.3 (21.1) 30.3 (19.4) 
Vigorous  PA (min.day-1) 11.8 (16.1) 16.7 (18.1) 8.17 (13.1) 
Moderate-equivalent PA (min.day-1) 56.9 (45.0) 70.9 (49.1) 46.7 (38.4) 
Moderate-equivalent PA 10min bouts (min.day-
1) 
29.2 (32.3) 36.5 (35.9) 23.8 (28.1) 
Active individuals (≥150 min.week-1 moderate-
equivalent PA in bouts; %) 
47.0 56.5 40.0 
Data presented as Mean (SD) for continuous variables and as % for categorical variables.  577 
PAL - Physical activity level. *Central obesity was defined as WC >88 cm for women and >102 578 
cm for men. 579 
 580 
 581 
